Comparing Fasenra vs Singulair
| Fasenra (benralizumab) | Singulair (montelukast) |
|
|---|
| Fasenra (benralizumab) | Singulair (montelukast) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
[Fasenra](https://www.drugs.com/fasenra.html) is a biologic that may be used to treat severe eosinophilic asthma in adults and children aged 6 years and older or eosinophilic granulomatosis with... View more |
Prescription only
Singulair is used in addition to other treatments for the maintenance treatment of asthma. It does not relieve acute attacks and may cause neuropsychiatric effects in a small number of people... View more |
||||||||
| More about Fasenra (benralizumab) | More about Singulair (montelukast) | ||||||||
| Ratings & Reviews | |||||||||
|
Fasenra has an average rating of 7.8 out of 10 from a total of 76 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 16% reported a negative effect. |
Singulair has an average rating of 6.6 out of 10 from a total of 221 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 30% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Fasenra side effects |
View all Singulair side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Singulair prices |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
360 hours |
5.5 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 22 drugs are known to interact with Fasenra:
|
A total of 115 drugs are known to interact with Singulair:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 14, 2017 |
February 20, 1998 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.